“Myxovirus resistance, osteopontin and suppressor of cytokine signaling 3 polymorphisms predict hepatitis C virus therapy response in an admixed patient population: comparison with IL28B” (2013) Clinics, 68(10), pp. 1325–1332. doi:10.1590/clin.v68i10.77009.